SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 24.61-4.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: xomadog2 who wrote (9008)3/9/1999 1:14:00 PM
From: Thomas J Pittman  Read Replies (2) of 17367
 
Isnt the point that people have to die since the
assumption is that when we unblind the results
we will see a large statistically significant
difference in the numbers of those who died on
the placebo and those who died on newprex?
If only three died and two died on the placebo
and one died on the drug, i guess the fda
could conclude 1) that the disease can currently
be adequately treated with existing technologies
since people are dying or 2) that there
wasnt enough difference in treatment/nontreatment
to justify a new drug.

But God help them if they unblind it and find that
there were no deaths on the drug and yet the trial
was allowed to continue with sick kids getting
sugar pills.

I am probably just slow on the uptake. Maybe all
of this is obvious to everyone else. Or maybe
its wrong. Maybe I am just so eager for these guys
to get something right so I can take my money
and go home.

J
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext